PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-152394 | Pharmaceutics
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Preimplantation Genetic Diagnostics (PGD) Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET
7.1 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Illumina Inc
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Rubicon Genomics
16.3 Perkinelmer Inc
16.4 Thermo Fisher Scientific Inc
16.5 Natera Inc
16.6 Agilent Technologies Inc
16.7 Yikon Genomics
16.8 ABBott Laboratories
16.9 Cooper Surgical
16.10 Oxford Gene Technology
16.11 FUJIFILM Irvine Scientific
16.12 Merck
16.13 Scigene
16.14 IVFtech
16.15 Nidacon International
16.16 Hamilton Thorne
16.17 Beijing Genomics Institute (BGI)
16.18 INVO Bioscience
16.19 Vitrolife AB
16.20 Genea Limited
16.21 Gonagen Medikal
16.22 Cook Medical
16.23 CellCura
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Market by Application :
Fertility Clinics
Academic Medical Centers
Others
Companies
Illumina Inc
Rubicon Genomics
Perkinelmer Inc
Thermo Fisher Scientific Inc
Natera Inc
Agilent Technologies Inc
Yikon Genomics
ABBott Laboratories
Cooper Surgical
Oxford Gene Technology
FUJIFILM Irvine Scientific
Merck
Scigene
IVFtech
Nidacon International
Hamilton Thorne
Beijing Genomics Institute (BGI)
INVO Bioscience
Vitrolife AB
Genea Limited
Gonagen Medikal
Cook Medical
CellCura
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.